The ease of genetically engineering mice has led to the development of disease model strains that precisely mimic human conditions. These strains provide the ideal testbed for evaluating novel ...

Phase II Study of Afatinib in Patients With Tumors With Human Epidermal Growth Factor Receptor 2–Activating Mutations: Results From the National Cancer Institute–Molecular Analysis for Therapy Choice ...